At a glance
ClinicalIndex Comparison RecordN/ACompleted· 42 enrolled
Drug / intervention
Marathon® XL No Sting Cyanoacrylate Skin Protectant and 3M™ Cavilon™ Advanced Skin Protectantdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Evaluation of the Skin Protection Characteristics of Two Commercially Available Skin Barrier Protectants
In Brief
A clinical study evaluating Marathon® XL No Sting Cyanoacrylate Skin Protectant and 3M™ Cavilon™ Advanced Skin Protectant for Skin Hydration in Healthy Volunteers. Completed, enrolled 42 participants across 1 site.
Detailed Summary
The current study will evaluate the duration of wear and durability of two commercially available SBPs: Medline Marathon® XL (extra long) No Sting Cyanoacrylate Skin Protectant (henceforth referred to as "Marathon®") and 3M™ Cavilon™ Advanced Skin Protectant (henceforth referred to as "Cavilon™").
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Hydration in Healthy Volunteers
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartOct 2022
Primary CompletionNov 2022
First PostedMar 2023
TodayJul 2026
First PostedMar 6, 2023
Enrollment StartOct 6, 2022
Primary CompletionNov 22, 2022
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 3.3 years ago
Interventions
Marathon® XL No Sting Cyanoacrylate Skin Protectant and 3M™ Cavilon™ Advanced Skin Protectantdevice
All participants will receive both device interventions listed above.